pharmaceutical intermediates buyer

Popular tags

Popular on the whole site

Additionally, the effectiveness of probiotics is often determined by their potency, which is measured in colony-forming units (CFUs). A sufficient dose is essential for achieving the desired health benefits. Many products on the market contain varied CFU counts, ranging from millions to billions. Therefore, it is crucial for consumers to choose high-quality supplements that provide the appropriate CFU count and contain well-researched strains of probiotics.


In 2020, the growth of China’s API export was stimulated by the epidemic, which boosted the global demand for ANTI-epidemic APIS, and also affected the production of other major API producers such as India and the European Union. As a result, the transfer orders of China’s API from the international market increased.  Specifically, the export quantity of China’s API increased by 7.5% year on year, reaching 10.88 million tons.  From specific export category, anti-infection, vitamins, hormones, antipyretic analgesic, part of antibiotic resistance to disease related API category of export amount is mostly realized the different levels of growth, some specific varieties is growing rapidly, such as dexamethasone exports rose 55% year-on-year, lamivudine, vitamin C, vitamin E and other exports more than 30% year-on-year growth,  Paracetamol, annannin and other exports year-on-year growth of more than 20%.

In summary, sulfamic acid is a versatile chemical that greatly benefits various industries, including cleaning, metallurgy, and agriculture. Its unique properties enable it to perform effectively in descaling and cleaning applications while also being a valuable reactant in chemical synthesis. Understanding the behavior and applications of sulfamic acid allows industries to harness its potential while observing necessary safety protocols. With continued research and development, the uses of sulfamic acid may expand, affirming its position as an important compound in the chemical industry.


Sustainability is becoming an increasingly important consideration in the API supply chain. Environmental regulations and consumer preference for eco-friendly practices are pushing suppliers to adopt greener manufacturing processes. This includes minimizing waste, reducing energy consumption, and incorporating renewable resources in the production of APIs. Pharmaceutical companies are prioritizing partnerships with suppliers that demonstrate a commitment to sustainability while maintaining high-quality standards.


1. Research and Development (R&D) The initial phase of API production is R&D, where scientists focus on developing new compounds that could lead to effective drugs. This phase includes screening potential molecules, optimizing synthesis routes, and conducting preclinical studies.


The production and quality of APIs are stringently regulated by health authorities around the world, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These organizations demand that APIs meet specific standards for purity, potency, and stability to ensure that healthcare professionals can provide safe and effective treatments.


Polyacrylamide is produced through the polymerization of acrylamide monomers. This polymer can exist in various forms, including anionic, cationic, and nonionic types, each tailored for specific applications based on the charge and functional groups present. The flexibility in formulations allows polyacrylamide to be engineered for optimal performance in the intended application.


Links